The Prostate Program
Prostate care at RPCI integrates surgical, radiation and medical oncology specialists tailoring personalized care plans from diagnosis through long-term follow-up. Robot-assisted surgery
and other minimally invasive techniques are now used to perform almost 100% of prostate cancer surgeries at RPCI. RPCI pioneered the Prostate-Specific Antigen (PSA) test that is used
worldwide in the detection and management of prostate cancer.
RPCI’s Prostate Program provides comprehensive, individualized prostate cancer care for about 200 inpatient admissions and over 7,000 outpatient visits annually.